NUCB2 and injury: Indeed, Hui et al. (2021) showed that NUCB2/nesfatin-1 reduces inflammation in a mouse model of acute lung injury induced by lipopolysaccharide (LPS, also known as endotoxin), through inhibiting neutrophil accumulation and inflammatory cytokine expression [12].